Also known as: OEA · oleoylethanolamide · N-oleoylethanolamine

OEA (Oleoylethanolamide)

A lipid signaling molecule made by your own body — not a cannabis terpene, despite the article brief.

Sourced and fact-checked
7 cited sources
Published 1 hour ago
How this page was made
↯ The honest take

Heads up: OEA is not a terpene and it is not produced by the cannabis plant. It's an endogenous fatty acid ethanolamide — a cousin of anandamide — made in your gut and other tissues, where it regulates appetite and fat metabolism. It gets mentioned in cannabis circles because it shares biosynthetic machinery with the endocannabinoids, but classifying it as a cannabis terpene is simply wrong. Here's what OEA actually is, and why the confusion exists.

Editorial note: this isn't a terpene

The assignment asked for a terpene article on OEA. We can't write one honestly, because OEA is not a terpene and is not a constituent of Cannabis sativa. Terpenes are plant-derived hydrocarbons built from isoprene units (C5H8 building blocks). OEA is a nitrogen-containing lipid amide — an oleic acid molecule joined to ethanolamine. It is synthesized by animals, including humans, primarily in the small intestine [1][2].

The likely source of confusion is that OEA belongs to the same chemical family as anandamide (AEA), the endogenous cannabinoid. Both are N-acylethanolamines (NAEs) made by overlapping enzymatic pathways. But OEA does not bind CB1 or CB2 cannabinoid receptors at physiologically meaningful affinities [3]. We're publishing this entry as a correction rather than a strain-style profile.

What OEA actually is

OEA is the ethanolamide of oleic acid (an 18-carbon monounsaturated fatty acid). It's biosynthesized on demand from membrane phospholipid precursors via the NAPE-PLD pathway, the same general route that produces anandamide, and it's degraded mainly by fatty acid amide hydrolase (FAAH) [2][3]. Tissue levels rise after feeding in the proximal small intestine and fall during fasting — a pattern opposite to anandamide [1][4].

Its main molecular target is PPAR-α, a nuclear receptor that controls fatty acid oxidation and satiety signaling. OEA binds PPAR-α with sub-micromolar affinity and triggers receptor-dependent reductions in food intake in rodents [4][5]. It also activates GPR119 and TRPV1 at higher concentrations [3].

Where it's found

OEA is endogenous to mammals. The highest concentrations are in the jejunum and duodenum of the small intestine, with measurable levels in liver, brain, adipose tissue, and plasma [1][2]. Dietary oleic acid (abundant in olive oil) is a substrate for intestinal OEA synthesis, which is one reason high-oleate diets are studied for satiety effects [4][6].

It is not present in cannabis flower, trichomes, or extracts in any meaningful sense. Cannabis produces phytocannabinoids and terpenes; OEA-class lipids are animal metabolites.

Effects research: preclinical vs human

Preclinical (strong in rodents): OEA reliably reduces food intake, prolongs the interval between meals, promotes lipolysis, and increases fatty acid oxidation in rats and mice. These effects are abolished in PPAR-α knockout animals, establishing the mechanism [4][5]. Strong evidence for rodent satiety effects via PPAR-α.

Human evidence (limited): Small clinical studies have measured circulating OEA in relation to obesity, eating disorders, and dietary fat intake, with inconsistent results [6][7]. A handful of trials have tested OEA-related supplements (e.g., N-oleoyl-phosphatidylethanolamine, marketed as Riduzone) for appetite and weight, with modest effects of uncertain clinical significance [7]. Weak / limited for human weight-loss benefit from oral OEA-precursor supplements.

Interaction with cannabis: Because FAAH degrades both anandamide and OEA, FAAH inhibitors (some of which have been studied as cannabinoid-adjacent drugs) raise OEA levels alongside AEA [3]. This is biochemically interesting but not a reason to call OEA a cannabis compound.

Strains dominant in OEA

None. There are no cannabis strains "dominant in" OEA because cannabis plants do not produce OEA. If a product or marketing page claims a strain is "high in OEA," that's a red flag for a misunderstanding of basic biochemistry — or worse, deliberate misinformation.

If you're interested in cannabis compounds that genuinely interact with the endocannabinoid system, look at the phytocannabinoids (THC, CBD, CBG, etc.) and the actual plant terpenes such as myrcene, limonene, and beta-caryophyllene.

OEA's actual chemical family is the N-acylethanolamines, not terpenes. Close relatives include:

All of these share the FAAH/NAPE-PLD metabolic machinery, which is why pharmacology that perturbs one tends to perturb the others [2][3].

Sources

How this page was made

Generation history

May 16, 2026
Fact-check pass — raised 2 flags
May 16, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.